MergerLinks Header Logo

Request Deal Involvement

Xeris Pharmaceuticals to acquire Strongbridge Biopharma for $267m.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Arthur Cox

legal advisors

Arthur Cox

MTS Health Partners

financial advisors

MTS Health Partners

Skadden Arps Slate Meagher & Flom

legal advisors

Skadden Arps Slate Meagher & Flom

Elixir Health Public Relations

pr advisors

Elixir Health Public Relations

Joele Frank

pr advisors

Joele Frank

Gibson Dunn & Crutcher

legal advisors

Gibson Dunn & Crutcher

A&L Goodbody

legal advisors

A&L Goodbody

Goodwin Procter

legal advisors

Goodwin Procter

Leerink Partners

financial advisors

Leerink Partners

or

Principals

STRONGBRIDGE

target

STRONGBRIDGE

XERIS PHARMACEUTICALS

bidder

XERIS PHARMACEUTICALS

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Xeris Pharmaceuticals to acquire Strongbridge Biopharma for $267m.